1. [Recurrent early pregnancy loss: What the life-birth chances are? A 10-years retrospective study].
- Author
-
Bonne S, Sananes N, and Rongières C
- Subjects
- Abortion, Habitual diagnosis, Abortion, Habitual etiology, Adult, Diagnosis, Differential, Embryo Loss diagnosis, Embryo Loss epidemiology, Embryo Loss etiology, Embryo Loss therapy, Female, Humans, Infant, Newborn, Pregnancy, Prognosis, Recurrence, Retrospective Studies, Thrombophilia complications, Thrombophilia diagnosis, Thrombophilia epidemiology, Abortion, Habitual epidemiology, Abortion, Habitual therapy, Birth Rate, Pregnancy Outcome epidemiology
- Abstract
Objectives: Recurrent miscarriages are a current consultation pattern. Etiologic evaluation is classically proposed and preventive therapy should be discussed. We wanted to study our University Hospital pregnancies outcomes, following 3 repetitive early miscarriages, and how those patients are managed., Materials and Methods: A 10-years retrospective study has been performed in our center, with 296 patients found having a three-repetitive miscarriage experience. Information about diagnostic evaluation following miscarriages, preventive therapy initiation, and next pregnancy outcome has been provided., Results: Around 62.5% of the patients experienced a life-birth. When investigations were done (n=148), a 64.9% part of the patients had abnormal results. Life-birth rate was more important when there were normal karyotypes or no thrombophilia found (respectively p equal 0.30 and 0.45). We noticed a better prognostic in the group of patients with normal investigations results who had a preventive therapy (n=20, 85% of life-birth, P=0.19)., Conclusion: When done, investigations for recurrent miscarriages, allow the finding of an abnormality in two thirds of cases. Wonderingly, outcomes are very encouraging since that almost two thirds of the patients experienced life-birth. Investigations indications, results interpretations, and consecutive therapy should be well thought but preventive therapy seems to be efficient in the normal results patient group., (Copyright © 2014 Elsevier Masson SAS. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF